logo

Ascendis Pharma A/S (ASND)



Trade ASND now with
  Date
  Headline
6/3/2019 7:30:32 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) FY19 Rev. Estimate To 5.5 M From 0.1 M
6/3/2019 7:30:07 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) FY20 Estimate To -4.33 From -4.27
6/3/2019 7:29:55 AM Wedbush Is Lowering Ascendis Pharma A/S (ASND) Q4 20 Estimate To -1.12 From -1.11
6/3/2019 7:29:42 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q3 20 Estimate To -1.10 From -1.08
6/3/2019 7:27:02 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q2 20 Estimate To -1.07 From -1.05
6/3/2019 7:26:46 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q1 20 Estimate To -1.05 From -1.03
6/3/2019 7:25:58 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) FY19 Estimate To 2.75 From -3.91
6/3/2019 7:25:24 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) Q4 19 Estimate To 0.39 From -1.04
6/3/2019 7:25:13 AM Wedbush Is Raising Ascendis Pharma A/S (ASND) Q3 19 Estimate To 0.39 From -1.03
6/3/2019 7:24:59 AM Wedbush Is Raising Ascendis Pharma A/S (ASND) Q2 19 Estimate To 0.43 From -0.94
6/3/2019 7:24:32 AM Wedbush Reiterates Ascendis Pharma A/S (ASND) At Outperform With $223 Up From $219 Price Target
11/28/2018 4:14:33 PM Ascendis Pharma Q3 Loss/share EUR 0.81 Vs. Los EUR 1.04 Year Ago
8/29/2018 4:03:05 PM Ascendis Pharma A/S Q2 Loss/share EUR 0.55 Vs. Loss EUR 0.94 Year Ago
5/30/2018 4:03:13 PM Ascendis Pharma A/S Q1 Loss/share EUR 1.07 Vs. Loss EUR 0.78 Year Ago
5/15/2018 7:49:03 AM Wedbush Reiterates Ascendis Pharma A/S (ASND) At Outperform With $76 Price Target